Autolymphocyte therapy: Filed an IND for a Phase I trial

Cellcor Inc. (CLTX), Newton, Mass. Product: Autolymphocyte therapy Indication: Treat chronic hepatitis B Status: Filed an IND for a Phase I trial in nine patients who have failed interferon treatments...